Two days after Debra Demidon underwent in vitro fertilization, she gained more than 30 pounds in fluid and suddenly was struggling to breathe.Doctors diagnosed severe ovarian hyperstimulation syndrome (OHSS), a complication seen in some women who undergo fertility treatment. It landed Ms. Demidon in

This research aimed to develop the population-based preference scores of the EQ-5D-5L (the 5L), Thai version in an effort to compare the measurement properties of the 5L with those of the EQ-5D-3L (the 3L), and to compare the results of an economic evaluation from a 2014 study that used the 5L compared with the 3L. To elicit population-based prefer

Reference: Tarn YH, Hu S, Kamae I, Yang BM, Li SC, Tangcharoensathien V, Teerawattananon Y, Limwattananon S, Hameed A, Aljunid SM, Bapna JS. Health-care systems and pharmacoeconomic research in Asia-Pacific region. Value Health. 2008;11(Suppl 1):S137-55. Link: http://www.ncbi.nlm.nih.gov/pubme

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Kalipso Chakidou1*, Ryan Li1, Anthony J. Culyer2, Amanda Glassman3, Karen J. Hofman4, Yot Teerawattananon5 1Institute of Global Health Innovation, Imperial College London, London, UK 2Department of Economics & Related Studies and Centre for Health Economics, University of York, York, UK 3Ce

Abstract Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and res

Sildenafil is a treatment option for PAH patients that is found to offer an additional 1-3 life years gained for PAH patients compared to beraprost, currently the only treatment available in the benefit package under the National Social Health Insurance (Jaminan Kasehatan Nasional – JKN) of Indonesi

Due to the increasing burden of non-communicable diseases (NCDs) in aging populations and the prevalence of unhealthy lifestyles, end-stage renal disease (ESRD) that results from NCDs is a growing concern in Indonesia. With the target of achieving Universal Health Coverage (UHC) by 2019, public prov